Manufacturer
Sun Pharmaceutical Industries Limited
Contents
Valsartan
Indication
Hypertension, Post-myocardial infarction, Heart failure
Instruction
May be taken with or without food.
Drug interaction
Increased risk of hyperkalaemia with K-sparing diuretics (e.g. spironolactone, triamterene, amiloride), K supplements or K-containing salt substitutes (e.g. heparin). May increase serum lithium concentration and toxicity. May antagonise hypotensive effect and deteriorate renal function with aspirin, NSAIDs including selective COX-2 inhibitors. Increased systemic exposure with rifampicin, ciclosporin, and ritonavir.Potentially Fatal: Increased risk of hypotension, hyperkalaemia and reduced renal function including acute renal failure with aliskiren in patients with diabetes mellitus. Increased risk of angioedema with ACE inhibitors.
Malaysia
